Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Springerplus|November 7, 2015
Stem cell transplantation therapy in Parkinson's diseaseMu-Hui Fu, Chia-Ling Li, Hsiu-Lien Lin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2008
Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucomaBrian P Buckingham, Denise M Inman, Wendi Lambert, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primatesDavid J Calkins, Patrick Yu-Wai-Man, Nancy J Newman, et al.
Human Molecular Genetics|April 12, 2012
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extensionPeizhong Mao, Maria Manczak, Marcus J Calkins, et al.
Antioxidants (Basel, Switzerland)|March 29, 2023
Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwaySarah Naguib, Carlisle R DeJulius, Jon R Backstrom, et al.
International Journal of Molecular Sciences|March 25, 2022
Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in MiceJoseph M Holden, Sara Al Hussein Al Awamlh, Louis-Philippe Croteau, et al.
Investigative Ophthalmology & Visual Science|April 4, 2008
Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucomaAlejandra Bosco, Denise M Inman, Michael R Steele, et al.
Biochimica Et Biophysica Acta|November 1, 2011
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeuticsP Hemachandra Reddy, Raghav Tripathi, Quang Troung, et al.
Annals of Hematology|August 30, 2022
Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesisShih-Chiang Lin, Chi-Yuan Yao, Cheng-An Hsu, et al.
Antioxidants & Redox Signaling|August 23, 2008
The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative diseaseMarcus J Calkins, Delinda A Johnson, Jessica A Townsend, et al.
Pageof 18